Introduction
We studied the adhesion of primitive and committed progenitors from chronic myelogenous leukemia (CML) and normal bone marrow to stroma and to several extracellular matrix components. In contrast to benign primitive progenitors from CML or normal bone marrow, Ph'-positive primitive progenitors from CML bone marrow fail to adhere to normal stromal layers and to fibronectin and its proteolytic fragments, but do adhere to collagen type IV, an extracellular matrix component of basement membranes. Similarly, multilineage colony-forming unit (CFU-MIX) progenitors from CML bone marrow do not adhere to fibronectin or its adhesion promoting fragments but adhere to collagen type IV. Unlike committed progenitors from normal bone marrow, CML single-lineage burst-forming unitserythroid and granulocyte/macrophage colony-forming units fail to adhere to fibronectin or its components but do adhere to both collagen type IV and laminin. Evaluation of adhesion receptor expression demonstrates that fibronectin receptors (a4, a5, and 131 ) are equally present on progenitors from normal and CML bone marrow. However, a fraction of CML progenitors express a2 and a6 receptors, associated with laminin and collagens, whereas these receptors are absent from normal progenitors. These observations indicate that the premature release of malignant Ph'-positive progenitors into the circulation may be caused by loss of adhesive interactions with stroma and/or fibronectin and acquisition of adhesive interactions with basement membrane components. Further study of the altered function of cell-surface adhesion receptors characteristic of the malignant clone in CML may lead to a better understanding of the mechanisms underlying both abnormal expansion and abnormal circulation of malignant progenitors in CML. (J. Clin. Invest. 1992. 90:1232-1241.) Key words: bone marrow stroma extracellular matrix,* integrins coding sequences of the bcr gene on chromosome 22 and 3' coding sequences ofthe c-ablgene on chromosome 9 (bcr/abl) occurs (2) . Clinically, CML is characterized by an abnormal expansion of the malignant Ph'-positive stem cell clone, although presumed normal, Ph '-negative stem cells may coexist in some patients with CML (3) (4) (5) . Primitive and committed malignant Ph'-positive myeloid progenitors leave the bone marrow microenvironment prematurely and circulate in the peripheral blood ofpatients with CML (6) . It has been demonstrated that primitive progenitors present in the peripheral blood of patients with CML have a diminished capacity to adhere to normal bone marrow derived stromal layers when compared with bone marrow-derived hematopoietic progenitors from normal individuals (7, 8) . Studies evaluating the adhesion of bone marrow-derived CML progenitors to either intact irradiated stromal layers or to different components of such stroma have not been performed.
Bone marrow stromal cells and/or extracellular matrix molecules have an important role in the regulation of the human hematopoietic stem cell (9) . Such stromal layers provide both proliferation and differentiation stimuli (9-1 1) . Stroma provides also factors such as transforming growth factor-e (TGF1gb), which have the capacity to inhibit the proliferation of primitive hematopoietic progenitors ( 10, 11) . It has been suggested that mechanisms that either promote or restrict the generation ofmore mature hematopoietic elements are only operative when primitive hematopoietic progenitors are in close proximity to stromal elements (12) . The dysregulated hematopoiesis in CML could, therefore, be secondary to the inability of malignant CML primitive progenitors to adhere to bone marrow stromal elements.
Bone marrow-derived stroma consists of multiple cell types ( 13) and a variety ofextracellular matrix molecules ( [14] [15] [16] [17] [18] . Several extracellular matrix components have been implicated in the adhesion of committed hematopoietic progenitors 1 . Abbreviations used in this paper: BMMNC, bone marrow mononuclear cells; CML, chronic myelogenous leukemia; IMDM, Iscove's modified Dulbecco's medium; LTBMC long-term bone marrow culture(s). (14) (15) (16) (17) . Recently, we have demonstrated that receptors which can interact with the 33/66-kD COOH-terminal heparin-binding cell-attachment fragment of fibronectin may play an important role in the adhesion of primitive hematopoietic cells with long-term in vitro repopulating capacity to irradiated stromal layers and hence, to the bone marrow microenvironment ( 18) . Upon differentiation into more committed clonogenic cells, human hematopoietic progenitors alter their adhesive capacity and are capable ofinteracting with other cell-attachment sites of the fibronectin molecule (15, 16, 18) and other extracellular matrix components ( 17).
We have previously described (3) were purified further in an initial counterflow elutriation step as previously described (3). Negative and positive selections for primitive progenitors were performed using previously described methods (3, 18, 19 Laboratories, Logan, UT), 2 mM L-glutamine, penicillin 1,000 U/ml, streptomycin 100 U/ml (Gibco Laboratories, Grand Island, NY), and 10-6 M hydrocortisone (A-Hydrocort) (Abbott Laboratories, North Chicago, IL). Panning. Alternatively, CML and normal DR' and DR-cell populations were panned on allogeneic irradiated stroma in LTBMC media for 2 h, the stroma was washed extensively with warm IMDM and the nonadherent cells were recovered in the panning effluent (7, 8, 19) . The cells recovered in the panning effluent were then plated onto sec-ondary stromal layers in order to determine the number ofLTBMC-initiator cells (IC) which failed to adhere to normal allogeneic stroma during the initial panning experiment.
Maintenance ofcultures. All LTBMC cultures were maintained in a humidified atmosphere at 370C and 5% Co2. At weekly intervals the cultures were fed by removing half of the supernatant and replacing it with fresh media. Nonadherent cells recovered in the supernatant as well as adherent cells recovered from selected stromal layers after treatment with 0.1% collagenase were assayed weekly in short-term methylcellulose assay for the presence of colony-forming cells.
It is believed that committed progenitor cells present in the initial bone marrow population fail to produce clonogenic cell growth in LTBMC 4-5 wk after initiation ofsuch cultures. The number ofclonogenic cells recovered from both adherent and nonadherent layers of LTBMC at 5 wk of culture may therefore represent progeny of more primitive progenitors which can sustain long-term in vitro hematopoiesis and are termed LTBMC initiator cells or LTBMC-IC (19) (20) (21) . Purification of collagen type I, collagen type IV, laminin, fibronectin, andfibronectin fragments.
Human plasma fibronectin was purified as a by-product of factor VIII production by sequential ion exchange and gelatin chromatography (22) . A 75-kD tryptic fragment containing the cell binding fragment RGDS was purified from long-term (90') tryptic digestion as previously described (22) . The 33-and 66-kD COOH-terminal heparin binding fragments were purified from short-term ( 15') tryptic/catheptic digests of intact fibronectin by sequential heparin and antibody column chromatography as described (22) . The purity of intact fibronectin, the 33/66-kD fragment and the 75-kD fragment of fibronectin was verified by SDS-PAGE and Coomassie Brilliant Blue staining.
Collagen type IV and laminin were isolated from the EngelbrethHolm-Swarm tumor grown subcutaneously in Swiss Webster mice (Simonson Laboratories, CA). The mice were made lathyritic by adding 0.1% ,B-amino proprionitrile to their water, using previously described techniques (23) .
Collagen type I (Vitrogen) was obtained from the Collogen Corp., Palo Alto, CA.
Cell adhesion assays
Substrata were prepared as follows: collagen type I, collagen type IV, laminin, fibronectin, and proteolytic fragments from fibronectin were diluted to the appropriate concentrations in Voller's carbonate buffer (22) 10 jg of mouse IgG (Sigma Chemical Co.), 75 ng of anti-HLA-DR-biotin, 75 ng allophycocyanin, and 75 ng anti-CD34-PE. Control stains consisted ofIgG I -PE, IgG2a-biotin followed by APC and mouse-IgG followed by FITC. Antibodies against the receptor (1 (P4C10) were a generous gift from Dr. Elizabeth Wayner (University of Minnesota); antibodies against the a2, a4, a5, and a6 receptors were obtained from AMAC Inc., Westbrook, MA; anti-CD34-PE, anti-HLA-DR-biotin and APC were obtained from Becton Dickinson & Co., goat anti-mouse-IgG-FITC was obtained from Tago Inc. Control samples were labeled with IgGl-PE, IgG2a-biotin followed by APC or mouse IgG followed by goat anti-mouse-FITC.
Statistical analysis
Results of experimental points obtained from multiple experiments were reported as the mean± 1 SEM. Significance levels were determined by two-sided Student's t test analysis.
Results
Adhesion of LTBMC-IC to normal allogeneic irradiated stroma. In a first set of experiments we evaluated the adhesion of primitive progenitors capable of long-term in vitro hematopoiesis (LTBMC-IC) present in the CML DR-, CML DR', and normal DR-bone marrow populations to normal irradiated allogeneic stroma. FACS-sorted bone marrow fractions were panned for 2 h on irradiated allogeneic stroma (7, 8, 19) . Stromal layers were then washed extensively, and adherent cells cultured further for 5 wk. At 5 wk the cultures were evaluated for the presence of secondary committed progenitors.
LTBMC-IC present in both the normal and the CML DR cell fraction adhered to irradiated stroma (Table II) . The number of secondary clonogenic cells recovered from long-term cultures initiated with panned CML DR-cells was similar to that recovered from long-term cultures initiated with plated CML DR-cells at any time during the culture. Cells recovered in the panning effluent after panning with CML DR-cells were significantly depleted of LTBMC-IC. These results are similar to those previously presented for LTBMC-IC derived from the DR -fraction of normal bone marrow. This suggests that LTBMC-IC present in the DR-cell fraction of CML bone marrow have similar adhesive characteristics as LTBMC-IC present in bone marrow of normal individuals (Table II) .
In contrast, LTBMC-IC present in the DR' fraction of CML bone marrow did not adhere to irradiated stroma. Panning of CML DR' cells followed by culture of the adherent cells for 5 wk in long-term cultures resulted in the recovery of significantly fewer committed cells compared with experiments in which CML DR' cells were plated on irradiated stroma (Table II) . Moreover, virtually all LTBMC-IC present in the CML DR+ cell fraction were recovered in long-term cultures initiated with cells recovered in the panning effluent after panning stromal layers with CML DR' cells (Table II) .
These findings indicate that in contrast to benign DR-LTBMC-IC present in bone marrow from CML patients or from normal individuals, malignant DR+ primitive progenitors from CML bone marrow fail to adhere to stromal layers. A possible explanation for these differences in adhesion between LTBMC-IC in the DR-fraction of CML and normal bone Adhesion ofprimitive LTBMC-IC to extracellular matrix components. We then evaluated the adhesion of benign and malignant LTBMC-IC to different extracellular matrix components. Because the DR-content in CML bone marrow is 10-100-fold smaller than that of normal bone marrow (3) secondary to the expansion ofthe more mature myeloid cell compartment, recovery of sufficient numbers of CML DR-cells to assess their adhesion to ligand-coated wells is technically impossible. The adhesion of LTBMC-IC present in the DR-fraction of normal and CML bone marrow to irradiated stromal layers is similar. Consequently, we compared the adhesion of malignant LTBMC-IC present in the DR' bone marrow fraction of CML patients with that of benign LTBMC-IC present in the DR-fraction from normal individuals.
Cells were plated in wells coated with increasing concentrations of fibronectin and its proteolytic fragments, collagen type IV, laminin, and collagen type I. Adherent fractions were then cultured in LTBMC to enumerate the number of LTBMC-IC present in the adherent cell populations. Results shown represent the degree of adhesion ofdifferent progenitor populations to wells coated with the highest concentrations of ligands.
In contrast to LTBMC-IC in normal bone marrow (Fig. 1  B) ( 18) , malignant CML LTBMC-IC failed to adhere to either intact fibronectin (P = 0.11), its 33/66-kD COOH-terminal heparin-binding fragment (P = 0.07) or its 75-kD RGDS-dependent cell-binding fragment (P = 0.1 ) (Fig. 1 A) . However, a small but significant fraction of CML LTBMC-IC adhered to the extracellular matrix component collagen type IV (P = 0.004) (Fig. 1 C) whereas normal LTBMC-IC failed to do so (P = 0.3) (Fig. 1 D) . Adhesion of either malignant CML LTBMC-IC or LTBMC-IC derived from normal bone marrow to wells coated with collagen type I and laminin (Fig. 1, C and  D) was not significantly greater than that to control BSAcoated wells.
Adhesion ofcommitted progenitors to extracellular matrix components. We then evaluated the adhesion of committed multilineage CFU-MIX and single-lineage BFU-E and CFU-GM progenitors in the DR' fraction of either CML or normal bone marrow to fibronectin, collagen type IV, laminin, and collagen type I. DR' cells were allowed to adhere to ligand coated wells for 3 h. The adherent cell fraction was then plated in methylcellulose culture to evaluate the number of adherent CFU-MIX, BFU-E, and CFU-GM progenitors.
As previously reported (18) , adhesion of normal CFU-MIX progenitors occurred only to the 33/66-kD heparin-binding adhesion fragment of fibronectin (Fig. 2 B) . No significant adhesion was observed to fibronectin nor its 75-kD proteolytic fragment, collagen type IV (P = 0.15), laminin (P = 0.35), or collagen type I (P = 0.15) (Fig. 2, B and D) . In contrast, CML CFU-MIX progenitors failed to adhere to the 33/66-kD fragment offibronectin (Fig. 2 A) but 22% adhered to collagen type IV (P < 0.001) (Fig. 2 C) . No significant adhesion was observed to laminin (Fig. 2 C) and collagen type I (Fig. 2 C) .
Normal BFU-E and CFU-GM adhered to a significant extent to fibronectin and both its proteolytic fragments (Figs. 3 B  and 4 B) ( 18) . Adhesion of these normal progenitors to the other tested extra-cellular matrix molecules was insignificant (Figs. 3 D and 4 D) . In contrast, adhesion of CML single-lineage BFU-E (Fig. 3 A) and CFU-GM (Fig. 4 A) to fibronectin and its proteolytic fragments did not reach significance. 20-30% of CML BFU-E (P < 0.001) and CFU-GM (P = 0.003) adhered, however, to collagen type IV (Figs. 3 C and 4 C) and in addition to the extracellular matrix molecule laminin (P < 0.001 for BFU-E and P = 0.017 for CFU-GM), another component of basement membranes (Figs. 3 C and 4 C) . Adhesion ofsuch progenitors to collagen type I (Figs. 3 Cand 4 C) was not significant.
Cell-surface adhesion receptor expression. We finally evaluated the presence of adhesion receptors from the 31-integrin family on CML DR' and normal DR' and DR-progenitors. Partially purified bone marrow populations from seven chronic phase CML patients and seven normal individuals were sequentially labeled with antibodies against integrin receptors, the CD34 antigen, and the HLA-DR antigen and then analyzed using three-color FACS. Results were analyzed by sequential gating on cells with low-very low horizontal light scatter properties and low vertical light scatter properties. Using antibody control stains, a second selection was performed for cells expressing high levels of the CD34 antigen and either presence or absence ofthe HLA-DR antigen. This final population was then evaluated for the expression ofintegrin receptors by frequency histogram. Fig. 5 D) were plated in wells coated with collagen type I (100 gg/ml), collagen type IV (80 ,g/ml), laminin (100 .g/ml), fironectin (100 jug/ml), its 33/66 kD proteolytic fragment (60 jig/ml), its 75-kD proteolytic fragment (40 jug/ml), or BSA control wells for 3 h at 370C and 5% CO2. Adherent cells were cultured in short-term methylcellulose culture and the number of CFU-MIX colonies present enumerated at days 16 were plated in wells coated with collagen type I (100 ,g/ml), collagen type IV (80 ,g/ml), laminin (100 ,g/ml), fibronectin (100 sg/ml), its 33/66-kD proteolytic fragment (60 ,g/ml), its 75-kD proteolytic fragment (40 ,g/ml) or BSA control wells for 3 h at 370C and 5%
CO2. Adherent cells were cultured in short-term methylcellulose culture and the number of BFU-E colonies present enumerated at days [16] [17] [18] [19] [20] [21] were plated in wells coated with collagen type I (100 lg/ml), collagen type IV (80 ,g/ml), laminin (100 jsg/ml), fibronectin (100 ,gg/ml), its 33/66-kD proteolytic fragment (60 ,g/ml), its 75-kD proteolytic fragment (40 ,g/ml), or BSA control wells for 3 h at 370C
and 5% CO2. Adherent cells were cultured in short term methylcellulose culture and the number ofCFU-GM colonies present enumerated at days 16-21 of culture. Percent adhesion was calculated as: (the number ofCFU-GM adherent to ligand coated wells/the total input CFU-GM) x 100. 
Discussion
The adhesion of cells to adjacent cells or to the surrounding extracellular matrix is fundamentally important for the maintenance of normal adult tissue structure and function. Ordered hematopoietic development is believed to depend not only on the interaction of the most primitive hematopoietic progenitors with specific cellular and extracellular components of the bone marrow microenvironment, but also on the trafficking of less primitive hematopoietic progenitors to specific sites of differentiation within the bone marrow. Ultimately mature blood elements are released from the bone marrow into the peripheral blood. Such processes require multiple, discrete recognition events which occur in a cell type-and developmental stage-specific fashion. The most primitive hematopoietic progenitors which can reconstitute long-term in vitro hematopoiesis found in the DR-fraction ofhuman bone marrow are capable of adhering within 2 h to bone marrow-derived stroma (7, 8, 19) . This adhesion to stroma is in part mediated through cell surface adhesion receptors that are responsible for the interaction of such progenitors with the 33/66-kD COOH-terminal heparin-binding cell-attachment fragment of fibronectin ( 18 Ph '-negative, bcr/abl nonrearranged primitive progenitors can be separated from their malignant counterparts on the basis of HLA-DR expression (3) . Such benign progenitors in the DR-fraction of CML bone marrow demonstrate similar adhesion to irradiated stromal layers as their counterparts found in the DR-fraction ofbone marrow obtained from normal individuals. In contrast, the majority of malignant, primitive progenitors in the DR' population of CML bone marrow fail to adhere to preformed, stromal layers. These observations are consistent with the reports from Gordon and co-workers, who demonstrated that primitive progenitors with self-renewal capacity derived from CML peripheral blood adhere poorly to preformed stromal layers (7, 8) . Because we used preestablished, irradiated stromal layers generated from the bone marrow of normal individuals, we believe that an intrinsic adhesive defect in malignant CML hematopoietic progenitors underlies their reduced adhesion. The adhesive properties of malignant primitive progenitors from CML bone marrow are reminiscent of those of committed progenitors found in the DR' fraction of normal bone marrow ( 19) . However, the majority ofclonogenic cells in normal individuals are usually retained in the bone marrow microenvironment, whereas uncommitted and committed malignant CML progenitors are circulating. This suggests additional differences in adhesive properties between both uncommitted and committed progenitors in CML and hematopoietic progenitors from normal individuals.
In addition to their inability to interact with intact stromal layers, malignant DR' CML progenitors demonstrate significantly decreased adhesion to fibronectin. In contrast to normal multipotential LTBMC-IC and CFU-MIX, which adhere significantly to the 33/66-kD COOH-terminal heparin-binding cell-attachment fragment of fibronectin (18) , malignant LTBMC-IC and CFU-MIX from CML bone marrow fail to do so. We demonstrate also that malignant BFU-E and CFU-GM from CML bone marrow fail to adhere to either intact fibronectin, its 75-kD RGDS-containing or 33/66-kD heparin-binding cell-attachment fragments. However, similar bone marrow fractions from normal individuals have the ability to interact with fibronectin and with both proteolytic fragments ( 18) . Receptors involved in the adhesion of normal hematopoietic progenitors to fibronectin are in part responsible for their adhesion to intact stromal layers ( 18 ) . Failure of malignant progenitors from CML bone marrow to interact with fibronectin may therefore in part explain their premature release from the bone marrow into the peripheral circulation. The second major difference observed between hematopoietic progenitors from normal bone marrow and malignant progenitors in CML bone marrow is the ability of a small fraction of the latter to adhere to collagen type IV and laminin. Both laminin and collagen type IV are almost exclusively found in basement membranes where they comprise the majority of proteins (29, 30) . Malignant transformation of cells is generally accompanied by molecular alterations in the adhesive behavior of the tumor cells compared with their non-malignant counterparts (31, 32) . These alterations generally enable tumor cells to escape from their usual environment and to disseminate. During the process of intra-or extravasation, malignant cells must penetrate subendothelial basement membranes. Malignant tumor cells are therefore likely to acquire the ability to adhere to basement membrane proteins and to express adequate numbers ofadhesion receptors which interact with collagen type IV or laminin (33) . The capacity of 20-30% of malig-nant CML hematopoietic progenitors to adhere to laminin and collagen type IV may facilitate their egress from the bone marrow into the circulation. However, not all CML malignant progenitors are capable of adhering to these extracellular matrix components under the above described test conditions. This may indicate that other as yet not identified mechanisms may have a separate or accessory role in the abnormal trafficking of CML progenitors.
The adhesive phenotype of malignant CML progenitors resembles that of mature blood elements. This is consistent with the clinical observation that numerous immature progenitors circulate in the blood of patients with CML. The mechanism(s) by which normal mature blood elements are released from the bone marrow microenvironment into the circulation are not well known. A developmentally regulated decrease in function and/or expression of adhesion receptors on hematopoietic progenitors may result in their release in the circulation. Upon maturation into reticulocytes and mature red blood cells, erythroid precursors progressively loose their capacity to adhere to fibronectin ( 15, 16) . Similarly, it has been demonstrated that granulocytic progenitors adhere to hemonectin whereas mature circulating granulocytes have lost this capacity ( 17) . However, before entering the circulation, mature blood elements need to cross the basement membrane ofthe capillary endothelium lining the venous sinusoids of the bone marrow. Mature leukocytes (27) , monocytes (25) , and lymphocytes (34) in the circulation have the capacity to adhere to laminin. This enables these cell populations to interact transiently with basement membranes and diapedese out of the blood vessels into tissue compartments. Similarly, platelets adhere to the subendothelial matrix of injured vessel walls as an initial step in the formation of a hemostatic plug (35) . This adhesion involves interaction with laminin and collagen type IV through integrin receptors (25) (26) (27) 34) . The same adhesive mechanisms may in part be responsible for the release of normal mature blood elements from the normal bone marrow microenvironment and malignant immature hematopoietic progenitors from the CML bone marrow microenvironment.
We are currently defining the cell-surface receptors responsible for the adhesion of normal LTBMC-IC and their more committed progeny to intact stromal layers or to fibronectin. To elucidate the molecular events underlying the altered adhesion of CML progenitors, it will be necessary to evaluate both quantitative and qualitative differences in cell-surface adhesion receptors between CML progenitors and their benign counterparts. Decreased expression of receptors involved in cellular adhesion such as the LFA-3 molecule, has been demonstrated in CML (35) . Here we describe an additional aberration in the adhesive phenotype of malignant CML progenitors. In contrast to normal 34k/DR-and 34+/DR' progenitors, 22% of CML 34+/DR' progenitors express high levels of a2 and a6-integrin receptors, associated with adhesion to collagens and laminin. Surprisingly, adhesion receptors associated with fibronectin (a5f3l = RGD dependent and a4f31 = CSI dependent) are expressed to the same extent on CML progenitors and immature hematopoietic progenitors from normal bone marrow. The malignant phenotype of CML progenitors may therefore be associated not only with aberrant expression of adhesion receptors but also with changes in the functional status of such receptors. Anchorage-independent growth of fibroblasts has been demonstrated after transfection of NIH-3T3 fibroblasts with Rous sarcoma virus which results in the generation ofa neo-protein, pp6OsRC. This neo-protein has increased tyrosine kinase activity similar to that of the p210bcr/aIl kinase. This enzyme can be found in close proximity with the cell membrane, can induce phosphorylation ofintegral membrane proteins and can alter their function (36). Similarly, transformation of the hematopoietic progenitor in CML results in the abnormal distribution of the p210cr/abl tyrosine kinase in the cell cytoplasm rather than the normal distribution of the p 156 tyrosine kinase product from c-abl in the nucleus (37, 38) .
This altered distribution may change the functional status of cell surface adhesion receptors resulting in impaired adhesion of the malignant population to bone marrow-derived stromal elements. Further studies evaluating the molecular alterations resulting in the abnormal adhesive properties of malignant CML hematopoietic progenitors will help to elucidate the abnormal differentiation and circulation of hematopoietic progenitors in CML.
